BTX

BlackRock Technology and Private Equity Term Trust
NYSEFINANCIAL SERVICESASSET MANAGEMENT

Key Statistics

Market Cap
$1.06B
P/E Ratio
2.35
EPS
$3.85
Beta
—
52W High
$9.32
52W Low
$5.72
50-Day MA
$8.65
200-Day MA
$7.75
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00

About BlackRock Technology and Private Equity Term Trust

Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA$-25.72M
Operating Margin0.00%
Return on Equity-427.20%
Return on Assets-35.30%
Revenue/Share (TTM)$0.00
Book Value$0.26
Price-to-Book0.84
Price-to-Sales (TTM)2.35
EV/Revenue2.352
EV/EBITDA0.06
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$116.71M
Float$34.05M
% Insiders0.00%
% Institutions29.69%

Historical Volatility

HV 10-Day
24.40%
HV 20-Day
20.15%
HV 30-Day
21.77%
HV 60-Day
29.97%
HV Rank
22.2%

Volatility is currently expanding

Latest News

BTX: AI Technology Trading At A Deep Discount

BlackRock Technology and Private Equity Term Trust offers diversified public and private equity exposure centered on the AI investment theme. BTX provides access to top private AI companies like Anthropic, OpenAI, Databricks, and Anduril, alongside major public semiconductor and storage names. Shares currently trade at a -12.16% discount to NAV, presenting an arbitrage opportunity, with a robust 7.03% yield from capital gains and ROC.

Seeking Alpha9/23/2026Positive
BTX: No One Is Interested In Free Exposure To Anthropic

BlackRock Technology and Private Equity Term Trust aims for 80% tech exposure, blending public and private holdings, including a notable Anthropic stake. We analyze the fund's performance since inception and since the management change. We go over the rationale for our rating.

Seeking Alpha7/8/2026Neutral
BTX: A Strategy Reset, A 17% Discount, And Retail Access To Frontier AI

BlackRock Technology and Private Equity Term Trust is a Buy, offering a unique blend of AI infrastructure equities and private frontier AI holdings at a wide NAV discount. BTX's portfolio reset post-February 2025 delivers concentrated exposure to NVIDIA, AI supply chain leaders, and rare private stakes in Anthropic, OpenAI, PsiQuantum, and Deepgram. A 17%+ market price discount to NAV, paired with a 32% private equity allocation (mostly preferred stock), creates a compelling risk/reward profile for AI cycle participation.

Seeking Alpha4/21/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BTX and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More FINANCIAL SERVICES Stocks

Data last updated: 9/26/2026